VBI Vaccines rallies 11% on funding to advance COVID-19 vaccine – Seeking Alpha

Canada's Strategic Innovation Fund has awarded up to C$56M to VBI Vaccines (NASDAQ:VBIV) to support the development of its COVID-19 vaccine program VBI-2900 through Phase 2.

The company is currently collaborating with the National Research Council of Canada on preclinical studies aimed at selecting the best candidate for clinical trials, expected to start by year-end.

Shares up11%on average volume.

More here:

VBI Vaccines rallies 11% on funding to advance COVID-19 vaccine - Seeking Alpha

Related Posts
Tags: